08:00 , Nov 24, 2003 |  BioCentury  |  Strategy

Genotyping for consumers

By licensing its haplotyping database to Sciona Ltd., pharmacogenomics company Genaissance Inc. has got its foot in the door of the consumer market, an arena where GNSC believes genetic variation information will be used, but...
07:00 , Sep 10, 2001 |  BioCentury  |  Finance

Ebb & Flow

A big week for FDA panel reviews will provide a major test for the biotech space in the wake of last week's post-Labor Day let-down. The big newsmakers will be Tuesday's Oncologic Drugs Advisory Committee...
07:00 , Sep 6, 2001 |  BC Extra  |  Financial News

Phoqus raises $19.2 million

Phoqus (Kent, U.K.) raised 13.2 million ($19.2 million) in a venture financing. Investors included Abingworth; Advent Venture Partners; Abbey National; Wellcome Trust; and 3i. Phoqus is developing an oral drug delivery platform based on electrostatic...
07:00 , Aug 6, 2001 |  BioCentury  |  Finance

Ebb & Flow

Integrative Proteomics...
07:00 , Jul 30, 2001 |  BC Extra  |  Financial News

Avlar starts 75 million fund

Avlar BioVentures launched its second fund, Avlar BioVentures Fund II, and announced the first closing of 38 million. The fund will raise 75 million ($107 million) and focus on seed and early stage investments in...
08:00 , Mar 5, 2001 |  BioCentury  |  Finance

Ebb & Flow

While hot life science technologies come and go, VCs are reminding themselves that patience, combined with fundamental investment strategies like targeting big markets, sound management and a solid business plan never go out of style....
07:00 , Apr 24, 2000 |  BioCentury  |  Finance

Old-fashioned values

That generosity wasn't provided to...